Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Prophylactic Use of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development After Excision of Previous Scar

NCT02708628 is registered in ClinicalTrials.gov with Suleymaniye Birth And Women's Health Education And Research Hospital as lead sponsor.

NCT NCT02708628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02708628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Prophylactic Use of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development After Excision of Previous Scar
Lead sponsor
Suleymaniye Birth And Women's Health Education And Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
October 31, 2016
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cicatrix